Cell line · CVCL_0161
Ba/F3
Factor-dependent cell line, Mus musculus. 43 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. Ba/F3. Cell lines, record CVCL_0161. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0161
On this page
Cell line
As Cellosaurus gives it.
- Name
- Ba/F3
- Accession
- CVCL_0161
- RRID
- RRID:CVCL_0161
- Synonyms
- BA/F3, BaF3, BAF3, Baf3
- Species
- Mus musculus (Mouse)
- Category
- Factor-dependent cell line
- Derived from
- Bone marrow (in situ)
- Cell type
- Pro-B cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse (PubMed=25277546). |
Source Cellosaurus
Papers43
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Systematic Targeting of Protein Complexes with Molecular COUPLrs. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Autoinhibition of the mechanosensitive lipid scramblase TMEM63B by its C-terminal tail. | J Biol Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor against Uncommon EGFR Mutations. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRASG12D Inhibitor. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Function-driven design of a surrogate interleukin-2 receptor ligand. | FEBS Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chronic ER Stress Triggers Cell-Surface Chaperones as the Therapeutic Targets of CAR Cells in Acute Myeloid Leukemia. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ARAP1 fine-tunes F-actin polymerization level in lymphocytes through RhoA inhibition. | Front Immunol | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 43
See all 43 papersRelatives253
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Abeomics Ba/F3 GFP | CVCL_D7B9 | Cell lines | |
| Derived from it | BA/F3/Cas9-hyg | CVCL_C9FI | Cell lines | |
| Derived from it | BL2-5-8 | CVCL_A8X0 | Cell lines | |
| Derived from it | BLG-139-3 | CVCL_A6ZF | Cell lines | |
| Derived from it | Ba/ER | CVCL_6C87 | Cell lines | |
| Derived from it | Ba/F3 AXL | CVCL_UE62 | Cell lines | |
| Derived from it | Ba/F3 BCR-ABL | CVCL_UE63 | Cell lines | |
| Derived from it | Ba/F3 BCR-ABL-T315I | CVCL_UE64 | Cell lines | |
| Derived from it | Ba/F3 BTK C481S | CVCL_UE65 | Cell lines | |
| Derived from it | Ba/F3 CSF1R | CVCL_UE67 | Cell lines |
1 to 10 of 253
See all 253 relativesCell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0161
GET https://conductscience.org/api/cell-lines/v1/CVCL_0161/papers?page=2